At the recent International Congress of Human Genetics in Montreal, Canada, Dr. Joseph Buxbaum presented findings indicating that insulin-like growth factor-1 (IGF-1) leads to improvements in brain functioning in mice lacking a copy of the Shank3 gene. In 2012, Dr. Buxbaum and his team will be conducting a clinical trial to find whether IGF-1 produces the same results in children lacking a copy of the gene.
For more information about the clinical trial and the presentation in Montreal, please read the full write-up by SFARI (Simons Foundation Autism Research Initiative) please click here.
To view all posts, click the “News & Events” tab on the left hand side.